Stockscreener 앱 받기
59.40
5.86%
3.29
시간 외 거래:
59.50
0.10
+0.17%
전일 마감가:
$56.11
열려 있는:
$56.04
하루 거래량:
2.80M
Relative Volume:
1.16
시가총액:
$10.99B
수익:
$2.69B
순이익/손실:
$-214.04M
주가수익비율:
-37.46
EPS:
-1.5857
순현금흐름:
$98.43M
1주 성능:
-3.02%
1개월 성능:
+12.71%
6개월 성능:
+35.00%
1년 성능:
-11.74%
1일 변동 폭
$55.98
$59.70
1주일 범위
$55.65
$62.15
52주 변동 폭
$40.62
$79.62
이그젝트 사이 Stock (EXAS) Company Profile
명칭
Exact Sciences Corp
전화
608-284-5700
주소
5505 ENDEAVOR LANE, MADISON, WI
EXAS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EXAS
Exact Sciences Corp
|
59.40 | 10.99B | 2.69B | -214.04M | 98.43M | -1.17 |
|
TMO
Thermo Fisher Scientific Inc
|
524.05 | 200.45B | 42.37B | 6.14B | 7.78B | 15.95 |
|
DHR
Danaher Corp
|
228.55 | 165.08B | 23.74B | 3.89B | 4.98B | 5.24 |
|
A
Agilent Technologies Inc
|
134.51 | 38.36B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
197.27 | 35.80B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
412.26 | 33.76B | 3.84B | 866.24M | 792.60M | 10.37 |
이그젝트 사이 Stock (EXAS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-08-28 | 개시 | Wells Fargo | Overweight |
| 2024-06-27 | 개시 | Scotiabank | Sector Outperform |
| 2024-06-03 | 재개 | Jefferies | Buy |
| 2024-01-02 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2023-12-14 | 개시 | Guggenheim | Buy |
| 2023-12-13 | 개시 | Wolfe Research | Outperform |
| 2023-10-10 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2023-09-28 | 개시 | Bernstein | Outperform |
| 2023-08-02 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2023-05-10 | 업그레이드 | Craig Hallum | Hold → Buy |
| 2023-05-05 | 개시 | UBS | Neutral |
| 2023-03-09 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-02-10 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2023-01-18 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2022-10-19 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-06-03 | 개시 | Piper Sandler | Neutral |
| 2021-11-03 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2021-07-29 | 재확인 | BTIG Research | Buy |
| 2021-07-29 | 재확인 | Canaccord Genuity | Buy |
| 2021-07-29 | 재확인 | Oppenheimer | Outperform |
| 2021-07-29 | 재확인 | Stifel | Buy |
| 2021-06-15 | 개시 | Raymond James | Strong Buy |
| 2021-06-03 | 개시 | Goldman | Buy |
| 2021-05-25 | 개시 | Wells Fargo | Equal Weight |
| 2021-01-28 | 개시 | Truist | Buy |
| 2020-10-29 | 다운그레이드 | UBS | Buy → Neutral |
| 2020-10-28 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-10-08 | 재개 | BTIG Research | Buy |
| 2020-04-02 | 개시 | Evercore ISI | Outperform |
| 2020-01-10 | 재개 | BTIG Research | Buy |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2019-12-13 | 개시 | Dougherty & Company | Buy |
| 2019-11-15 | 개시 | Stifel | Buy |
| 2019-10-17 | 재확인 | BofA/Merrill | Buy |
| 2019-10-01 | 재개 | Craig Hallum | Buy |
| 2019-09-26 | 개시 | Oppenheimer | Outperform |
| 2019-02-26 | 업그레이드 | Goldman | Neutral → Buy |
| 2018-10-09 | 개시 | UBS | Buy |
| 2018-09-05 | 재개 | The Benchmark Company | Hold |
| 2018-08-13 | 재확인 | Canaccord Genuity | Buy |
| 2018-04-03 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2018-01-29 | 개시 | Goldman | Neutral |
| 2018-01-08 | 재확인 | The Benchmark Company | Buy |
| 2017-11-13 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2017-11-01 | 다운그레이드 | BTIG Research | Buy → Neutral |
모두보기
이그젝트 사이 주식(EXAS)의 최신 뉴스
Tidal Investments LLC Grows Holdings in Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat
Exact Sciences Co. (NASDAQ:EXAS) Shares Sold by Toronto Dominion Bank - MarketBeat
Exact Sciences Co. (NASDAQ:EXAS) Shares Sold by Public Employees Retirement System of Ohio - MarketBeat
Exact Sciences (NASDAQ:EXAS) Price Target Lowered to $72.00 at Bank of America - MarketBeat
Exact Sciences Co. (NASDAQ:EXAS) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Groupama Asset Managment Acquires Shares of 1,204,952 Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat
Exact Sciences Corp reports results for the quarter ended in September 30Earnings Summary - XM
AAPA Awarded Grant from Exact Sciences to Improve Colorectal Cancer Screening Rates - Yahoo Finance
Pier Capital LLC Takes Position in Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat
Soros Fund Management LLC Boosts Holdings in Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat
Lil Jon Remixes Iconic ‘Get Low’ Hit To Promote Colon Cancer Screenings - Black Enterprise
Polar Asset Management Partners Inc. Acquires 45,800 Shares of Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat
Exact Sciences Co. (NASDAQ:EXAS) Shares Bought by Cerity Partners LLC - MarketBeat
Exact Sciences Corp (EXAS) Shares Up 4.18% on Dec 4 - GuruFocus.com
CFRA raises Exact Sciences to buy, target to $72 from $48 - Investing.com
Cinctive Capital Management LP Takes Position in Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat
The Manufacturers Life Insurance Company Acquires 35,927 Shares of Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat
Beacon Investment Advisory Services Inc. Cuts Stock Position in Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Cuts Stock Position in Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat
Exact Sciences and Lil Jon Partner on Get Low #2 Campaign to Encourage Colon Cancer Screening - El Diario NY
Lil Jon partners with Exact Sciences to raise awareness for colorectal cancer screening - The Atlanta Voice
Exact Sciences and Lil Jon Partner on “Get Low #2” Campaign to Encourage Colon Cancer Screening - Mid Florida Newspapers
Exact Sciences Co. (NASDAQ:EXAS) Shares Acquired by BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp - MarketBeat
30,536 Shares in Exact Sciences Co. (NASDAQ:EXAS) Bought by Fred Alger Management LLC - MarketBeat
392,139 Shares in Exact Sciences Co. (NASDAQ:EXAS) Acquired by Erste Asset Management GmbH - MarketBeat
Bellevue Group AG Grows Stock Holdings in Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat
Wasatch Advisors LP Reduces Stock Position in Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat
Exact Sciences Co. (NASDAQ:EXAS) Shares Sold by Braidwell LP - MarketBeat
Northwest & Ethical Investments L.P. Sells 36,242 Shares of Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat
Spyglass Capital Management LLC Has $95.17 Million Holdings in Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat
Fisher Asset Management LLC Sells 36,302 Shares of Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat
EXASExact Sciences Corp Latest Stock News & Market Updates - StockTitan
Soros Capital Management LLC Acquires Shares of 51,700 Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat
Exact Sciences stock lifted by TD Cowen, sees 10% revenue growth potential from CG+ - Investing.com Canada
Personalized Medicines Market to Surpass Valuation of USD 1352.81 Billion by 2031 | SkyQuest Technology - GlobeNewswire Inc.
Why Is Exact Sciences Stock Trading Higher On Tuesday? (CORRECTED) - AOL
Exact Sciences stock outlook improves with Cologuard Plus launch and Medicare reimbursement - Investing.com
Exact Sciences stock rating maintained outperform as Medicare pricing boosts CG+ outlook - Investing.com
Exact Sciences stock up 10%, BTIG raises target after 16% price increase for Cologuard Plus - Investing.com
Exact Sciences shares keep outperform rating on Medicare fee schedule boost - Investing.com
S&P 500 Futures Climb in Premarket Trading; Woodward, Exact Sciences Lead - Barron's
Exact Sciences to Participate in December 2024 Investor Conferences - BioSpace
Exact Sciences to Participate in December Investor Conferences - Business Wire
Exact Sciences Advances Breast Cancer Care with the Oncotype DX® test and Genomic Profiling Research at SABCS 2024 - El Diario NY
Exact Sciences to present 10 abstracts on Precision Oncology portfolio at SABCS - TipRanks
Exact Sciences Advances Breast Cancer Care with the Oncotype DX - Business Wire
Exact Sciences to Present 10 Key Studies on Breast Cancer Test Effectiveness at SABCS - StockTitan
Exact Sciences Co. (NASDAQ:EXAS) Position Trimmed by Victory Capital Management Inc. - MarketBeat
B. Metzler seel. Sohn & Co. Holding AG Buys Shares of 32,194 Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat
Exact Sciences data show multi-biomarker class approach improves MCED cancer detection - The Cancer Letter
Cathie Wood's ARK buys Tempus AI stock, sells Exact Sciences - Investing.com India
이그젝트 사이 (EXAS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
이그젝트 사이 주식 (EXAS) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Baranick Brian | EVP, GM, Precision Oncology |
Oct 08 '24 |
Sale |
70.00 |
929 |
65,030 |
12,758 |
0.72%
자본화:
|
볼륨(24시간):